Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $362.50-$519.88 |
Market Cap | $104.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $11.4B |
Revenue Growth (YoY) | 12.1% |
Gross Profit (12 Mos) | $5.9B |
Diluted EPS | $14.07 |
News
See moreYahoo Finance • 3 days ago
Healthy Aging Summit Highlights Urgent Need for Safer Pain Management Among Older New Jerseyans
Yahoo Finance • 5 days ago
5 Top Stocks to Buy in October
Yahoo Finance • 6 days ago
What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline
Yahoo Finance • 6 days ago
VRTX Quantitative Stock Analysis
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,100 |
